Brokers Issue Forecasts for PVLA FY2024 Earnings

Palvella Therapeutics (NASDAQ:PVLA – Free Report) – Equities research analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for Palvella Therapeutics in a note issued to investors on Thursday, December 26th. HC Wainwright analyst A. Fein forecasts that the company will post earnings per share of ($4.37) for the year. HC Wainwright […]

Leave a Reply

Your email address will not be published.

Previous post Jane Poole Acquires 59 Shares of Direct Line Insurance Group plc (LON:DLG) Stock
Next post Financial Analysis: Crown Castle (NYSE:CCI) versus ACRES Commercial Realty (NYSE:ACR)